Conclusion: Meeting the needs of hematologists
for training and knowledge in the subject of fertility preservation and ensuring the development of appropriate attitudes and practices in this area is an important issue.
Although the Red Cross and other blood centers agree that the blood is safe, some hematologists
believe that their policy of not using this blood is fear that the public might be concerned if they knew that some blood was coming from donors with "diseases."
Malcolm Moore calls that claim "outrageous." The development of an antibody to detect human Thyl "is the only original thing I see in this report," says Moore, who studies blood development at Sloan-Kettering Cancer Center in New York City.
For both new and experienced users, British hematologists
introduce data interpretation, quality control procedures, pitfalls and problems, and detailed protocols for flow cytometry.
Cancer Information Group (Dallas, TX) has begun the publication of Supportive Cancer Therapy, a new quarterly journal for practicing hematologists
at Vanderbilt University Medical Center in Nashville provide evidence that erythropoietin works not by initiating new red-cell production but by preventing the "programmed death" of very young red cells in bone marrow.
assemble 20 chapters that discus basic and clinical aspects of inherited and acquired defects associated with von Willebrand disease for hematologists
and thrombosis and hemostasis specialists.
The American Society of Hematology's 49th annual meeting and exposition at Atlanta's Georgia World Congress Center provides an interactive forum for hematologists
from around the world to discuss critical issues, listen to industry-leading experts, and visit a state-of-the-art exposition, which features the latest from pharmaceutical companies, medical suppliers, clinical-diagnostic and research-based companies, and many others.
This second edition covers additional trials and offers new reviews and section commentaries from internationally recognized pediatric oncologists and hematologists
. The section commentaries are written to focus on major conclusions from the studies presented and also on future research priorities.
have long relied on measures of individual cell density and size to obtain populations of older red blood cells.
These have pushed the envelope and moved hematologists
beyond simply identifying what is normal to accurately identifying abnormal and providing clinicians with effective therapies that enhance the quality of patients' lives.
and oncologists from Johns Hopkins and children's hospitals in London and Dublin present this third edition discussing malignant and benign disorders of the blood in children.